The Japan Times - The scientist rewriting DNA, and the future of medicine

EUR -
AED 4.030253
AFN 70.771844
ALL 89.950576
AMD 396.049299
ANG 1.964561
AOA 1007.297087
ARS 1717.08485
AUD 1.647335
AWG 1.975092
AZN 1.865972
BAM 1.953162
BBD 2.210924
BDT 136.535616
BGN 1.945982
BHD 0.413946
BIF 3297.305934
BMD 1.097273
BND 1.415601
BOB 12.90469
BRL 6.513192
BSD 1.097673
BTN 102.340607
BWP 15.506413
BYN 3.282532
BYR 21506.554514
BZD 2.207829
CAD 1.57445
CDF 2501.782932
CHF 0.926153
CLF 0.0283
CLP 1113.797734
CNY 7.315136
CNH 7.344631
COP 3760.761211
CRC 491.416215
CUC 1.097273
CUP 26.346421
CVE 110.577679
CZK 24.44055
DJF 195.007314
DKK 7.474312
DOP 66.057702
DZD 150.479012
EGP 59.05897
ERN 16.459098
ETB 180.180318
FJD 2.51731
FKP 0.834345
GBP 0.837861
GEL 2.842031
GGP 0.834345
GHS 12.920365
GIP 0.834345
GMD 81.197591
GNF 9721.840519
GTQ 8.392322
GYD 229.559196
HKD 8.604882
HNL 29.509149
HRK 7.496532
HTG 143.926946
HUF 373.285726
IDR 20052.667538
ILS 3.6198
IMP 0.834345
INR 102.400552
IQD 1664.252513
IRR 2125763.257256
ISK 137.20265
JEP 0.834345
JMD 173.735379
JOD 0.777935
JPY 175.204872
KES 142.722116
KGS 95.956622
KHR 4471.388232
KMF 492.675606
KPW 987.546255
KRW 1465.013367
KWD 0.341767
KYD 0.914885
KZT 494.234814
LAK 24721.564941
LBP 98260.813999
LKR 365.381587
LRD 184.388225
LSL 18.911485
LTL 3.239962
LVL 0.663729
LYD 7.104406
MAD 10.917257
MDL 20.144255
MGA 4956.351874
MKD 61.540316
MMK 2304.055787
MNT 3951.076717
MOP 8.870158
MRU 44.777694
MUR 51.396627
MVR 16.895038
MWK 1903.191616
MXN 20.942584
MYR 4.512867
MZN 70.111302
NAD 18.91226
NGN 1482.302958
NIO 40.393794
NOK 10.718899
NPR 163.775322
NZD 2.00073
OMR 0.421892
PAB 1.097827
PEN 3.745688
PGK 4.938331
PHP 70.049571
PKR 303.437979
PLN 4.438508
PYG 6882.705264
QAR 3.990611
RON 5.34808
RSD 117.631017
RUB 90.170062
RWF 1624.742887
SAR 4.118588
SBD 8.928557
SCR 15.205441
SDG 660.013387
SEK 11.188477
SGD 1.417655
SHP 0.830764
SLE 25.015602
SLL 23009.274168
SOS 627.358502
SRD 40.99424
STD 22711.339636
STN 24.465957
SVC 9.605029
SYP 14266.746379
SZL 18.907639
THB 37.284801
TJS 10.097669
TMT 3.840456
TND 3.326308
TOP 2.641971
TRY 55.366633
TTD 7.448974
TWD 36.240741
TZS 2918.730213
UAH 49.452317
UGX 4648.722142
USD 1.097273
UYU 44.559824
UZS 13151.239933
VES 1005.791274
VND 28260.270995
VUV 132.714229
WST 3.097911
XAF 655.957
XAG 0.024983
XAU 0.000299689239
XCD 2.965435
XCG 1.978437
XDR 0.775829
XOF 655.957
XPF 119.331742
YER 259.559968
ZAR 19.197381
ZMK 9876.783748
ZMW 22.55974
ZWL 353.321519
SSP 6451.526672
MXV 2.348208
  • RYCEF

    0.1000

    19.81

    +0.5%

  • VOD

    -0.2500

    16.33

    -1.53%

  • CMSC

    -0.2800

    20.12

    -1.39%

  • RBGPF

    -2.0000

    65

    -3.08%

  • RIO

    -0.2500

    94.16

    -0.27%

  • BTI

    -1.2000

    54.85

    -2.19%

  • NGG

    -0.3000

    74.94

    -0.4%

  • GSK

    -0.3500

    49.35

    -0.71%

  • BCE

    -0.4200

    20.14

    -2.09%

  • CMSD

    -0.3400

    19.93

    -1.71%

  • BP

    -0.9100

    43.52

    -2.09%

  • RELX

    0.1700

    33.24

    +0.51%

  • BCC

    -0.6200

    75.97

    -0.82%

  • AZN

    -1.9400

    164.21

    -1.18%

  • JRI

    0.0000

    10.77

    0%

The scientist rewriting DNA, and the future of medicine
The scientist rewriting DNA, and the future of medicine / Photo: Casey ATKINS - Broad Institute of Harvard and MIT,/AFP

The scientist rewriting DNA, and the future of medicine

A revolution is underway in gene editing -- and at its forefront is David Liu, an American molecular biologist whose pioneering work is rewriting the building blocks of life with unprecedented precision.

Text size:

A professor at the Broad Institute of MIT and Harvard, Liu was awarded a Breakthrough Prize in Life Sciences on Saturday for developing two transformative technologies: one already improving the lives of patients with severe genetic diseases, the other poised to reshape medicine in the years ahead.

He spoke with AFP ahead of the Los Angeles ceremony for the prestigious Silicon Valley-founded award.

He will receive $3 million for his work on "base editing" and "prime editing," and plans to donate most of it to support his charitable foundation.

"The ability to change a DNA sequence of our choosing into a new sequence of our choosing is a fundamentally very powerful capability," the 51-year-old said, foreseeing uses not just in human medicine but areas like developing more nutritious or disease-resistant crops.

- Correcting the code -

DNA is made up of four chemical "letters" -- the nucleotide bases A, G, T and C. Mutations in this sequence cause thousands of human diseases, yet until recently, gene editing could only fix a limited number of them.

Even CRISPR-Cas9, the groundbreaking technology that earned a Nobel Prize in 2020, has major limitations.

It cuts both strands of the DNA helix, making it most useful to disrupt rather than correct genes, while the process can introduce new errors.

"Being able to use genome editing to treat genetic diseases requires, in most cases, ways to correct a DNA misspelling, not simply to disrupt a gene," Liu said.

That insight led his lab to develop base editing, which uses the Cas9 protein -- disabled so it can no longer cut both DNA strands -- to find a target DNA sequence and another enzyme to convert one letter to another -- for example, C to T or G to A.

Reversing the change -- from T to C or A to G -- was tougher. Liu's team overcame the challenge by engineering entirely new enzymes.

These base editors can now correct about 30 percent of the mutations that cause genetic diseases. The technology is already in at least 14 clinical trials.

In one of them, Beam Therapeutics -- which Liu co-founded -- announced it had treated patients of AATD, a rare genetic disorder affecting the lungs and liver, with a single drug infusion.

While traditional gene therapies often disrupt faulty genes or work around them, base editing repairs the mutation itself.

"This was the first time that humans have corrected a mutation that causes a genetic disease in a patient," Liu said.

- Cystic fibrosis hope -

Base editing, quickly dubbed "CRISPR 2.0," can't fix every mutation.

About 70 percent of the roughly 100,000 known disease-causing mutations remain out of its reach, including those caused by missing or extra letters.

To expand the toolkit, Liu's lab introduced prime editing in 2019 -- a method capable of replacing entire sections of faulty DNA with corrected sequences.

If CRISPR is like scissors that cut DNA, and base editors are like using a pencil to correct individual letters, then prime editing is the equivalent of a word processor's "find and replace" function.

Creating this tool required a series of breakthroughs Liu's team describes as "small miracles." The result is, he said, "the most versatile way we know of to edit the human genome."

Among the targets Liu and his team have already pursued with prime editing: cystic fibrosis, a common genetic disease usually caused by three missing DNA letters that causes thick mucus buildup in the lungs and digestive system.

Liu's lab has made much of its work freely accessible, sharing DNA blueprints through a nonprofit library used by tens of thousands of labs worldwide.

"The science we create -- which is ultimately funded by society, through governments and donors -- ultimately goes back to benefit society."

This year's Breakthrough Prize awards come at a fraught moment for US science, as President Donald Trump's government strips funding for institutions like the National Institutes of Health (NIH).

"The NIH is a treasure, not just for this country but for the world," said Liu. "Trying to dismantle the heart of what supports science in this country is like burning your seed corn."

M.Fujitav--JT